Anzeige
Mehr »
Dienstag, 23.09.2025 - Börsentäglich über 12.000 News
Avanti Gold steigt um 1.500% - und steht womöglich erst am Anfang
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
22.09.25 | 21:08
1,590 Euro
-1,85 % -0,030
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6101,69014:40
1,6201,67014:39

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06:12China Medical System Holdings Ltd. (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies56SHENZHEN, CHINA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 September 2025, the Group through its subsidiaries...
► Artikel lesen
MoCMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING COLLABORATION AGREEMENTS FOR CLASS 1 INNOVATIVE BIOLOGIC RECOMBINANT HUMANIZED ANTI-TETANUS ...1
02.09.CMS (00867): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
02.09.CMS (00867): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND ...-
02.09.CMS (00867): INTERIM REPORT 20251
28.08.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR VITILIGO AND HIDRADENITIS SUPPURATIVA INDICATION OF INNOVATIVE ...1
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
19.08.China Medical System H1 Net Profit Rises1
19.08.China Medical System Holdings Ltd.: CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers749SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025...
► Artikel lesen
19.08.China Medical System profit up 3.1% in H14
18.08.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION2
18.08.CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025-
18.08.CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 AND RESIGNATION OF NON-EXECUTIVE DIRECTOR1
06.08.CMS (00867): NOTICE OF BOARD MEETING1
28.07.China Medical System Holdings Ltd. (867.HK, 8A8.SG)NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China1
28.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR THE TREATMENT OF MILD-TO-MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE OF ...1
23.07.China Medical System Holdings Ltd boosts global presence with Singapore Exchange listing4
21.07.China Medical System Holdings Limited: CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets466SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore...
► Artikel lesen
15.07.China Medical System Holdings Ltd.: A New Chapter Begins! CMS Achieves Secondary Listing on the Singapore Exchange Main Board Today474SHENZHEN, CHINA, July 15, 2025 (GLOBE NEWSWIRE) -- On the morning of 15 July 2025, China Medical System Holdings Limited ("CMS" or the "Group") rang the ceremonial bell to mark its official listing...
► Artikel lesen
15.07.CMS (00867): SUCCESSFUL SECONDARY LISTING ON THE SINGAPORE EXCHANGE-
14.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR ATOPIC DERMATITIS INDICATION OF INNOVATIVE DRUG HIGHLY SELECTIVE ...-
Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1